Cannapharmarx (CPMD) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CannaPharmaRx has secured the coveted IMC-GAP and GACP certifications, essential for selling cannabis in Israel, a market leader in medical cannabis. These international certifications underscore the company’s commitment to high-quality, safe, and environmentally sound cannabis production. CEO Dean Medwid highlights these milestones as key to the company’s global expansion and imminent product delivery to the Israeli market.
For further insights into CPMD stock, check out TipRanks’ Stock Analysis page.